Featured Research

from universities, journals, and other organizations

Children Should Not Take Antihistamines For Chronic Cough, Reviewers Say

Date:
April 20, 2008
Source:
Center for the Advancement of Health
Summary:
Chronic cough can cut into children's sleep and fray parents' nerves. Although antihistamines can alleviate cough, possible side effects outweigh their benefits, say authors of a new review of studies from Australia.

Chronic cough can cut into children's sleep and fray parents' nerves. Although antihistamines can alleviate cough, possible side effects outweigh their benefits, say authors of a new review of studies from Australia.

"In contrast to recommendations in adults with chronic cough, antihistamines cannot be recommended as empirical therapy for children with chronic cough," conclude reviewers led by Dr. Anne Chang.

The review adds to the growing body of evidence casting doubt on the use of a variety of medicines for children.

Cough is the most common symptom presented to general practitioners, said Chang. She is a consultant in pediatric respiratory medicine at the Royal Children's Hospital in Brisbane and the Menzies School of Health Research in Queensland.

A child is considered to have chronic cough after four weeks. A specific cough is associated with symptoms suggestive of an underlying problem. Nonspecific cough is nonproductive cough -- without gunk -- in the absence of identifiable respiratory disease.

Some children with nonspecific cough have asthma, but most do not. "Most nonspecific cough is likely post-viral," said Chang, who has been researching issues related to cough for the past decade. Children with nonspecific cough are treated with a variety of therapies, including antihistamines.

The review appears in a recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews like this one draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The reviewers examined five studies involving about 1,000 children, ranging from six months to 17 years old. Many children had allergies to things like grass, pollen or dust mites, or a family history of allergy.

Two larger studies "described significant improvement" both in children who took antihistamines and those who took placebos "with no significant difference between the two groups," the authors write.

A smaller study involving 20 school-age children found that cetirizine (Zyrtec) clinically improves cough due to pollen allergy. In that study, the antihistamine was significantly more effective than placebos in reducing chronic cough in children with allergies.

Another study examined the use of ketotifen (Zaditen) to minimize the frequency of asthma attacks in 113 infants ranging from six months to 36 months old. After a four-week no-medication baseline, infants received either a placebo or ketotifen for 16 weeks. Researchers concluded that they were "unable to show a therapeutic advantage of ketotifen over placebo."

Any effectiveness the drugs have should be weighed against their reported side effects, especially in young children, including "sedation, paradoxical excitability, dizziness, respiratory depression, hallucinations, arrhythmia and death," Chang writes.

In these studies, however, "most of the events reported were minor, with irritability and gastrointestinal upset being the most common events," the review says. Four children were withdrawn from one study. A dozen other children felt drowsy after taking medicine.

Chang said that the small study involving Zyrtec reported "no adverse effects."

Histamine, a compound found in nearly all tissues of the body, plays a role in allergic reactions. It is released in allergic conditions, including asthma, and gives rise to their symptoms. Antihistamine drugs inhibit histamine.

Still, all antihistamines are not equal, said Richard Irwin, past president of the American College of Chest Physicians.

The older antihistamines, such as Benadryl, have more anticholinergic activity, which is to say they "dry one out" more, said Irwin, a professor at the University of Massachusetts Medical School.

"These older drugs therefore can work when the cause of the upper airway cough is not due to allergies and they can also work if the cause of the cough is due to allergies," Irwin said. On the other hand, because the new drugs such as cetirizine [Zyrtec] or loratadine [Claritin] don't have much anticholinergic activity to speak of, they will only work if the cause of the upper airway cough is due to allergies."

Newer antihistamines, such as Zyrtec, "have been shown to be of help in children with allergic rhinitis," Irwin said. "The literature supports using these specific antihistamines when children have cough in association with seasonal allergies that involve the nose."

Beyond the research, parents continue to seek treatment for their children, spending billions of dollars worldwide on cough and allergy medications every year.

In children, it is important to elucidate the cause of the cough, Chang said. She recommends that physicians talk to parents about their fears and concerns, and says that parents who smoke should stop. When her own patients show up with a nonspecific cough, Chang uses a cautious, wait-see-and-review approach.

Reference: Chang AB, Peake J, McElrea MS. Antihistamines for prolonged non-specific cough in children (Review). Cochrane Database of Systematic Reviews 2008, Issue 2.


Story Source:

The above story is based on materials provided by Center for the Advancement of Health. Note: Materials may be edited for content and length.


Cite This Page:

Center for the Advancement of Health. "Children Should Not Take Antihistamines For Chronic Cough, Reviewers Say." ScienceDaily. ScienceDaily, 20 April 2008. <www.sciencedaily.com/releases/2008/04/080415194239.htm>.
Center for the Advancement of Health. (2008, April 20). Children Should Not Take Antihistamines For Chronic Cough, Reviewers Say. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/04/080415194239.htm
Center for the Advancement of Health. "Children Should Not Take Antihistamines For Chronic Cough, Reviewers Say." ScienceDaily. www.sciencedaily.com/releases/2008/04/080415194239.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins